Literature DB >> 12115730

Stress kinase p38 mediates EGFR transactivation by hyperosmolar concentrations of sorbitol.

Hao Cheng1, Jürgen Kartenbeck, Kirsten Kabsch, Xiahong Mao, Margarita Marqués, Angel Alonso.   

Abstract

Activation of the epidermal growth factor receptor (EGFR) has been shown to occur by ligand-dependent and ligand-independent mechanisms. Different molecular mechanisms have been found to be responsible for ligand-independent receptor transactivation. Here, we show that hyperosmolar concentrations of sorbitol activate the EGFR in human keratinocytes. Experiments using specific inhibitors of EGFR phosphorylation show that the increased amount of activated receptors is the result of a decreased rate of dephosphorylation. Furthermore, sorbitol treatment results in a strong activation of stress kinase p38. Treatment of the cells with SB203580, a known inhibitor of p38 alpha and beta kinases, results in impairment of receptor activation, indicating that the stress kinase is involved in receptor activation modulation. This is further reinforced by experiments showing that addition of Toxin B, known to be an inhibitor of the small Rho GTPases rac1, cdc42, and Rho A/B, to the cells results in a strong induction of EGFR activation. Our results point, therefore, to a mechanism by which osmotic shock activates EGFR through the small Rho GTPases-p38 stress kinase pathway. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115730     DOI: 10.1002/jcp.10134

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  16 in total

1.  Epidermal growth factor receptor is activated by hyposmolarity and is an early signal modulating osmolyte efflux pathways in Swiss 3T3 fibroblasts.

Authors:  Rodrigo Franco; Ruth Lezama; Benito Ordaz; Herminia Pasantes-Morales
Journal:  Pflugers Arch       Date:  2004-01-16       Impact factor: 3.657

Review 2.  Epidermal growth factor receptor is a common element in the signaling pathways activated by cell volume changes in isosmotic, hyposmotic or hyperosmotic conditions.

Authors:  R Lezama; A Díaz-Téllez; G Ramos-Mandujano; L Oropeza; H Pasantes-Morales
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

3.  Both sides of the same coin: Rac1 splicing regulating by EGF signaling.

Authors:  Xiang-Dong Fu
Journal:  Cell Res       Date:  2017-02-10       Impact factor: 25.617

4.  TRPV1 activation is required for hypertonicity-stimulated inflammatory cytokine release in human corneal epithelial cells.

Authors:  Zan Pan; Zheng Wang; Hua Yang; Fan Zhang; Peter S Reinach
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

5.  Elevated expression of RGS19 impairs the responsiveness of stress-activated protein kinases to serum.

Authors:  Angel K C Ip; Prudence H Tso; Maggie M K Lee; Yung H Wong
Journal:  Mol Cell Biochem       Date:  2011-11-02       Impact factor: 3.396

6.  Group VIA PLA2 (iPLA2β) is activated upstream of p38 mitogen-activated protein kinase (MAPK) in pancreatic islet β-cell signaling.

Authors:  Haowei Song; Mary Wohltmann; Min Tan; Shunzhong Bao; Jack H Ladenson; John Turk
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

7.  Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein.

Authors:  Ilana Chefetz; Danny Ben Amitai; Sarah Browning; Karl Skorecki; Noam Adir; Mark G Thomas; Larissa Kogleck; Orit Topaz; Margarita Indelman; Jouni Uitto; Gabriele Richard; Neil Bradman; Eli Sprecher
Journal:  J Invest Dermatol       Date:  2007-12-20       Impact factor: 8.551

8.  Retinal insulin receptor signaling in hyperosmotic stress.

Authors:  Raju V S Rajala; Ivana Ivanovic; Ashok Kumar Dilly
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

9.  Oxidative and osmotic stress signaling in tumor cells is mediated by ADAM proteases and heparin-binding epidermal growth factor.

Authors:  Oliver M Fischer; Stefan Hart; Andreas Gschwind; Norbert Prenzel; Axel Ullrich
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

10.  Immunological visibility: posttranscriptional regulation of human NKG2D ligands by the EGF receptor pathway.

Authors:  Pierre Vantourout; Carrie Willcox; Andrea Turner; Chad M Swanson; Yasmin Haque; Olga Sobolev; Anita Grigoriadis; Andrew Tutt; Adrian Hayday
Journal:  Sci Transl Med       Date:  2014-04-09       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.